![]() |
|||||||
| Imaging
Options An important imaging option that women should consider is the ImageChecker device. Used in conjunction with a mammogram, the ImageChecker is a computer-aided tool that uses pattern recognition software to identify suspicious lesions and assist radiologists in the early detection of breast cancer. Radiologists still look at the actual mammogram x-ray on a display unit but by pressing a button, the radiologist can also look at a digital version of the image with suspicious areas highlighted by the computer. Because mammograms are generally considered difficult to read and there can be a possibility of human error, the ImageChecker reduces the number of false negative readings thereby increasing the detection of early stage breast cancer by 20 percent. Although approved by the FDA in 1998, many women are still unaware of the ImageChecker and centers that offer it. Medicare and many insurance carriers across the country have now chosen to cover the cost of ImageChecker for their members yet many hospitals and centers still do not offer the service. To find out where your nearest ImageChecker device is located, please note the following list. Another
imaging device yet to be approved by the FDA is the Computed Tomography
Laser Mammography (CTLM). Already available internationally, this device
is a non-invasive and painless breast imaging system that uses laser
technology instead of harmful radiation or painful compression. Unlike
the black and white mammogram, CTLM provides a colorful three-dimensional
cross-sectional view of the breast. During the examination a patient
lies face down on a table with one breast suspended freely in the scanning
chamber. A laser beam scans the entire breast in 4 mm increments for
a period of up to 15 minutes. The diagnostic approach lies in the theory
that malignant tumors develop more blood vessels which absorb more of
the laser light and produce a whiter image than tissue in the surrounding
areas. Because preliminary indications show that CTLM could reduce the
amount of false positives due to its effectiveness at differentiating
between cysts and tumors, a number of the 700,000 out of 800,000 annual
biopsies reporting normal results could be avoided. Yuri Parisky, director
of the breast-imaging services at the USC/Norris Comprehensive Cancer
Center in Los Angeles concurs. “If we can say with 100 percent
accuracy that 20 to 30 percent of these [cases] shouldn’t go to
biopsy, we save some money and save some patients from needless worry.”
The CTLM test is expected to cost patients about $150. California Pacific Medical Center Hazel Hawkins Hospital Kaiser Permanente Kaiser Permanente Mammography Specialists Medical Corporation Palo Alto Medical Clinic Queen of the Valley Hospital Redwood Regional Medical Group Stanford University Medical Center Sutter Novato Community Hospital |
|||||||
|
Copyright © 2007 Bay Area Breast Cancer Network. All rights reserved. [Home] [We're Here] [Breast Health] [News & Views] [Voices] [Make a Difference] |
|||||||